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328a Monday, February 17, 2014exacerbated by elevated temperature. In summary, these results suggest tem-
perature fluctuations could be a trigger for long-QT and Brugada related
arrhythmias.
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Voltage gated sodium channels are membrane proteins that play a critical role
in electrical signaling of excitable cells. Amongst this family, the isoform
Nav1.5 is responsible for the initiation and propagation of cardiac action poten-
tials. As most of membrane proteins, Nav1.5 is well known to be a glycoprotein
with ~5% of its total weight corresponding to carbohydrates. To date, it has
been shown that Nav1.5 glycosylations such as sialylations influence biophys-
ical properties of this channel protein. However, whereas N-glycosylation are
well known post-traductional modifications that modulate surface localization
of many ionic channels, little is known about these maturation impacts on
voltage gated sodium channels. Perturbation of Nav1.5 trafficking is a well
characterized phenomenon occurring in pathology such as Brugada syndrome.
Our laboratory previously revealed that trafficking defective mutants of Nav1.5
exert a dominant negative effect upon wild type protein surface localization.
The objective of this study was (i) to characterize N-glycosylations of
Nav1.5 during its membrane trafficking and (ii) to investigate these maturations
in the context of the dominant negative effect exerted by Nav1.5 trafficking
defective mutations.
1664-Pos Board B394
Selective Inhibition of Late NaD Current Reduces Arrhythmic Activity in
Spontaneously Hypertensive Rat Myocytes
Nesrine El-Bizri, Steven Nguyen, Gongxin Liu, Luiz Belardinelli,
Sridharan Rajamani.
Gilead Sciences, Fremont, CA, USA.
The cardiac late Naþ current (INaL) is enhanced in hypertrophy, heart failure
and ischemia. Spontaneously hypertensive rats (SHR) are characterized by
prolonged action potential duration (APD), [Naþ]i and [Ca
2þ]i overload and
triggered activity (TA). We hypothesized that INaL is enhanced in SHR and
contribute to APD prolongation and TA. INaL was increased in ventricular my-
ocytes isolated from 10- to 12-month-old SHR (0.8450.13 pA/pF, n ¼ 16)
compared to age-matched Wistar rats (WR; 0.2650.06 pA/pF, n ¼ 9; p <
0.01). INaL inhibitors ranolazine (RAN) and GS-458967 (GS967) reduced
INaL in myocytes from SHR with IC50 of 3.750.1 and 0.6550.04 mM;
respectively. APD70 and APD90 were prolonged in myocytes from SHR,
compared to WR, and were shortened by RAN (10 mM) and GS967 (1 mM)
(Table). In 8/23myocytes from SHR, spontaneous delayed afterpotentials
(DADs) and/or TA were observed. Pacing induced DADs in 8/10 and TA
in 4/10 myocytes from SHR. GS967 (1 mM) abolished both spontaneous
and pacing induced TA (4/4).Our data
show that INaL is enhanced and contributes
to APD prolongation and TA in myocytes
from SHR. Selective inhibition of INaL
could stabilize cardiac repolarization and
suppress arrhythmias in hypertension.1665-Pos Board B395
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The late Naþ current (INa,L) is known to contribute to cardiac action potential
(AP) plateau and upregulation of INaL leads to arrhythmogenic activities. We
used an innovative self-action potential (sAP)-clamp technique to directly re-
cord the dynamic INa,L during the cell’s own AP. We studied the dynamic
INaL in rabbit ventricular myocytes under physiological conditions wherein
[Naþ]i and [Ca2þ]i homeostasis were preserved. We then determined the ef-
fect of GS967, a newly developed selective and potent inhibitor of INa,L. Re-
sults: (1) During the various phases of AP waveform, the dynamic INa,L
amplitude was low at phase-1, gradually increased during phase-2 to reach
a peak, and declined at phase-3. This profile of INa,L magnitude and time
course under AP-clamp is distinctively different from the monotonically
declining INa,L current seen under rectangular pulse voltage-clamp due to
non-equilibrium gating. (2) GS967 selectively inhibits INa,L during AP in a
concentration-dependent manner with an IC50 of 57 nM. Unlike tetrodotoxin,
GS967 did not significantly inhibit the fast Naþ current. Hence, GS967 short-ened the AP duration without affecting the AP upstroke. (3) The INa,L peak
amplitude was 0.7850.07 A/F under physiological condition. Anemonia
toxin II (ATX-II) at 5 nM increased the INaL amplitude to 1.25 50.14 A/
F, and prolonged APD95 from 212.4510.5 ms (control) to 305.6519.1 ms
(ATX-II). GS967 (1uM) effectively shortened APD and suppressed afterdepo-
larizations (EADs) induced by ATX-II. Conclusion: Our sAP-clamp data
reveal a surprisingly large INa,L during AP plateau under physiological con-
dition, which explains why INa,L significantly affect cardiac AP morphology
and arrhythmogenesis. GS967 inhibits INa,L during AP plateau without
blocking the fast Naþ current at AP upstroke, and therefore provides a prom-
ising therapeutic strategy to suppress cardiac arrhythmias without slowing
conduction.
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Nociceptive sensory neurons transmit painful stimuli from the periphery to the
central nervous system. Voltage-gated sodium (NaV) channels are instrumental
for the generation of the corresponding electrical signals, but - so far - the sen-
sory neuron-specific NaV1.9 only appeared to play a minor role. Recently, we
identified a de novo heterozygous mutation in the SCN11A gene encoding for
NaV1.9 and demonstrated the implication of NaV1.9 in human pain perception
(Leipold et al., Nature Genetics, DOI 10.1038/ng.2767). Surprisingly, in
affected individuals the mutation (L811P) leads to an inability to experience
pain by conferring gain-of-function (GOF) properties to NaV1.9. Mutant chan-
nels activate at hyperpolarized voltages and display a slow-down of channel
inactivation and deactivation, thereby causing sustained depolarization of noci-
ceptor cells and alterations of action potential characteristics. This new chan-
nelopathy is different from other pain-related NaV channel disorders: a GOF
of homologous NaV1.7 channels is associated with chronic pain, and loss of
functional NaV1.7 channels causes congenital indifference to pain. To gain
further insight into the mechanisms underlying the mutation we introduced
the homologous L-to-P mutation into channel isoforms NaV1.4 (L802P),
NaV1.7 (L957P) and NaV1.8 (L890P) and compared the functional parameters
of wild-type and mutant channels by means of the whole-cell patch-clamp tech-
nique. The L-to-P mutation shifted the activation in all channel subtypes to hy-
perpolarized potentials in the order NaV1.9 > NaV1.7 > NaV1.4 > NaV1.8.
Fast channel inactivation was slowed down most prominently in NaV1.9 and
NaV1.8, followed by NaV1.7 and NaV1.4. These results show that a homolo-
gous L-to-P mutation affects channel activation and inactivation in a subtype-
specific manner.
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Human mortality associated with status epilepticus (SE) in U.S and Canada is
21%-22%. Sudden death caused by epilepsy (SUDEP) accounts for 17% of all
SE-related casualties. Clinical evidence linked SUDEP to arrhythmias such as
conduction block and prolongation of the QT interval, an index of repolariza-
tion time, on the cardiac electrocardiogram. These observations suggest that
SE altered the activity of the cardiac sodium current (INa) involved in both
cardiac conduction and repolarization of the ventricle. We tested this hypoth-
esis by characterizing INa in ventricular cardiomyocytes of epileptic rats
induced induced by kainic acid injection. Our patch clamp results show that
epilepsy increased peak INa by 1856% and its sustained (late) component
(INaL) by 53513%. Activation of INa occurred at more negative potential in
epileptic rats and recovery from activation was significantly delayed by epi-
lepsy. Because epilepsy is known to increase the expression of neuronal chan-
nels (nNaVs) in the brain we next tested if the changes in INa were associated
with increased sensitivity to tetrodotoxin (TTX), a hallmark of nNaVs. Our
results indicate that TTX at a concentrations not affecting the cardiac sodium
channel NaV1.5 (1 nM) blocked 34% and 50% of INaL in Sham and epileptic
rats respectively. Epilepsy therefore increased the contribution of neuronal so-
dium channel to INa in the cardiac ventricle. In summary, our data indicate
that epilepsy altered INa in a manner consistent with the alterations of
Monday, February 17, 2014 329aconduction and QT prolongation observed in SUDEP and that TTX-sensitive
channels play an important role in these changes. Our results suggest a new
paradigm by which some of the arrhythmias observed during epilepsy are
not centrally mediated but also occur as a consequence of electrical remodel-
ing of the heart.
Voltage-gated Ca Channels II
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Rad/Rem/Rem2/Gem (RGK) proteins are Ras-like monomeric G-proteins that
powerfully potently inhibit all high-voltage-activated CaV1 and CaV2 calcium
channels. Since all RGKs bind auxiliary CaVbs it was generally assumed that
the RGK-b interaction is essential for CaV channel inhibition. Recently, using
a mutated b (bTM) which), which selectively loses the ability to interact with
RGKs, we reported that Rem inhibits CaV1.2 channels using both b-binding-
dependent and direct a1-binding-dependent mechanisms (Yang et al, 2013,
PLoS One, 7:e37079). Our aims here were twofold: (1) to identify determinants
and mechanisms underlying direct Rem binding to, and inhibition of, CaV1.2
pore-forming a1C subunit;; (2) to profile the relative prevalence of b-bind-
ing-dependent and -independent mechanisms of inhibition across the RGK
and CaV1/CaV2 channel families. Using a combination of FRET, co-
immunoprecipitation assays, systematic truncations, and whole-cell electro-
physiology we found that Rem C-terminus interacts with a1C N-terminus to
inhibit CaV1.2 current (ICa,L) and gating charge. For profiling, we compared
the impact of the four RGKs on currents through recombinant channels
(CaV1.3, CaV2.1, CaV2.2) reconstituted with either wt b2a or b2a,TM, respec-
tively. When reconstituted with wt b2a, all three channel types were strongly
inhibited by each RGK. By contrast, when reconstituted with b2a,TM, CaV1.3
and CaV2.1 were completely refractory to all four RGKs indicating these chan-
nels display only CaVb-binding-dependent mechanisms of inhibition. CaV2.2
channels reconstituted with b2a,TM displayed a strong inhibition solely to
Rad, identifying a second example of CaVb-binding-independent regulation
of a CaV channel by an RGK protein. The results reveal latent capabilities of
distinct RGKs to selectively inhibit particular CaV1/CaV2 channels in an
isoform-specific manner. These dormant capabilities may be exploitable to
develop novel genetically-encoded isoform-selective CaV1/CaV2 channel
inhibitors.
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Leucine-rich repeat containing 10 (LRRC10) is a cardiac-specific protein that
plays a critical role in cardiac function. We have demonstrated that the Lrrc10-
null (Lrrc10-/-) mice develop dilated cardiomyopathy. Our recent data indicate
that Lrrc10-/- cardiomyocytes exhibit reduced L-type Ca2þ channel (LTCC)
current (ICa,L). However, it is unclear how LRRC10 regulates ICa,L in the heart.
To investigate the role of LRRC10 in the regulation of LTCCs, we co-
expressed the Myc tagged LRRC10 (LRRC10-Myc), heamagglutinin tagged
Cav1.2 (Cav1.2-HA) and the auxiliary Cavb2C subunit in HEK293 cells and per-
formed co-immunoprecipitation (co-IP) on lysates using either anti-HA, anti-
Myc antibody or control IgG. Western blot analysis demonstrated that
Cav1.2 and LRRC10 associated with one another without the co-expression
of Cavb2C subunit. Also, the Cavb2C and LRRC10 did not co-IP with one
another suggesting that the LRRC10 may directly interact with Cav1.2 subunit.
We then tested if a single point mutation H150A or triple point mutations
Y104A, W127A and H150A would alter putative functional interaction sites
in the LRRC10 and investigated if these mutations disrupt LRRC10 association
with Cav1.2. Both LRRC10 mutants did not associate with Cav1.2. Addition-
ally, co-IP analysis using mouse ventricular homogenates demonstrated that
LRRC10 and Cav1.2 subunit are associated with one another. Finally, whole-
cell patch clamp experiments performed in ventricular myocytes from
Lrrc10-/- mice demonstrated a significant reduction in the ICa,L density (2.5
0.2 pA/pF) and delayed inactivation, compared to WT myocytes (6 0.6 pA/
pF). In summary, we demonstrate that the LRRC10 and Cav1.2 subunit ofLTCC may directly interact with one another and that mutations in LRRC10
residues, likely important for protein-protein interactions, disrupts this associ-
ation. We conclude that LRRC10 is a novel and essential regulator of the LTCC
function in ventricular myocytes.
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Distinguishing between allostery and competition among modulating ligands is
challenging for large target molecules. One key example of such ambiguity
concerns calcium-binding proteins (CaBPs) that tune signaling molecules regu-
lated by calmodulin (CaM). In L-type Ca2þ channels, CaBPs can potently elim-
inate CaM-dependent inactivation (CDI). However, the mechanism for this
modulation remains controversial. In past, using a live-cell holomolecule
approach, we resolved a cyclical allosteric binding scheme for CaM and
CaBP4 to CaV1.3 channels. In this scheme, both CaBP4 and CaM can simulta-
neously bind, resulting in strong inhibition of CDI despite the presence of a
covalently attached CaM (a), supporting an allosteric regulatory mechanism.
By contrast, Findeisen et al (J Mol. Biol. 425(17):3217-34) showed that fusion
of CaM to CaV1.2 channels prevents CaBP1 modulation, thus arguing for a
competitive regulatory mechanism. These results are confounded by limited
delivery of CaBPs through pipet dialysis. Here, we show that the CDI of
CaV1.2 channels with a fused CaM is
robustly inhibited by recombinantly ex-
pressed CaBP1 and CaBP4 (b). Thus, it ap-
pears that the cyclical allosteric scheme
first resolved in CaV1.3 now stands as a
common framework for CaBP modulation
of L-type calcium channels.
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The Ca2þ currents in inner hair cells (IHCs) are crucial for synaptic transmis-
sion and flow through voltage-gated calcium channels (VGCCs) formed by the
a1 subunit Cav1.3. VGCCs exhibit a calmodulin (CaM) mediated calcium-
dependent inactivation (CDI), via binding CAM to the channel’s C-terminus.
In IHCs, Cav1.3 exhibits unusually weak CDI, probably caused by calcium
binding proteins (CaBP) competing with CaM. IHCs express long and short
Cav1.3 splice variants either including (long variant, Cav1.3L) or excluding
(short variants) a C-terminal modulatory domain. In expression systems - lack-
ing CaBPs - the C-terminal modulatory mechanism (CTM) functions via intra-
molecular interaction of a proximal (PCRD) and a distal C-terminal regulatory
domain (DCRD) by inhibiting CaM binding near the PCRD, thereby inhibiting
CaM-mediated CDI (Bock et al., JBC 2011). Here, the role of the CTM for IHC
VGCCs was investigated in Cav1.3L-DCRDHA/HA mice in which CTM was
disrupted by partial replacement of the DCRD with an HA tag.
Localization of HA-tagged Cav1.3 channels in IHCs was determined by immu-
nohistochemistry. Channel properties were investigated by whole-cell patch-
clamp recordings. Hearing was assessed using auditory brainstem responses
(ABR) and distortion products of otoacoustic emissions (DPOAE).
Anti-HA immunolabeling was present at all IHC ribbons. Patch-clamp record-
ings revealed significantly reduced CDI and increased amplitudes of Ca2þ and
Ba2þ currents in Cav1.3L-DCRDHA/HA IHCs. Non-stationary fluctuation
analysis showed unchanged numbers of Cav1.3 channels and single channel
currents. Voltage dependence and activation kinetics of ICa and IBa, ABR
thresholds and DPOAEs were unaffected.
Our data demonstrate that the long Cav1.3 isoform is an intrinsic component of
Cav1.3 clusters at all IHC ribbon synapses and that its DCRD is required for
normal CDI and ICa amplitude.
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